To further clarify CLPTM1L’s role within the regulatory network involving ERLIN2 and SREBP1, we first examined the effects of CLPTM1L on ERLIN2 in NPC cells. This evidence concerns the gene CLPTM1L and nasopharyngeal carcinoma.